Surefire Precision Infusion System Registry
Stopped early
Conditions studied: Hepatocellular Carcinoma
In brief
This project involves the collection and analysis of retrospective and prospective data on patients diagnosed with hepatocellular carcinoma (HCC) in which the Surefire Precision Infusion System was used/will used be to deliver transarterial chemoembolization with doxorubicin-eluting beads (DEB-TACE). The purpose is to compare tumor and medical response in a real-world setting as well as identify potential areas for future clinical research.
Key facts
- Study ID
- NCT02967523
- Run by
- Surefire Medical, Inc.
- People needed
- 111
- Starts
- 2016-05-01
- Expected to finish
- 2018-06-18
- Last updated by the study team
- 2018-09-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who have undergone or will undergo DEB-TACE for HCC delivered by the Surefire® Precision Infusion System
- Patients aged 18 years or older
- Diagnosis of HCC
- Has a discrete hepatic artery(s) feeding the vessel with diameter(s) of the vessels ≥ 1.5 mm
You may not qualify if…
- Contraindications for doxorubicin administration
- Vessels providing flow to the tumor that are < 1.5 mm in diameter(s)
- Patients who are unable to provide informed consent
Where it is running
- UCLA — Los Angeles, California, United States
- USC — Los Angeles, California, United States
- UCSD — San Diego, California, United States
- Medstar Georgetown University Hospital — Washington D.C., District of Columbia, United States
- Florida Hospital — Orlando, Florida, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- University of Maryland Medical Center — Baltimore, Maryland, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- University Hospitals of Cleveland — Cleveland, Ohio, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.